PAREXEL Archives -

Four years after being taken private, Parexel has been sold again, with Goldman Sachs’ private equity arm and

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

https://pharmaphorum.com/news/private-equity-firms-play-pass-the-parexel-with-8-5bn-handover-deal/

Partnership aims to create tools to improve patient engagement and recruitment.

Microsoft, Parexel team up to accelerate drug development

https://pharmaphorum.com/news/microsoft-parexel-drug-development/

Study will focus on PAREXEL’s Perceptive MyTrials platform for gathering wearables data.

Parexel and Sanofi collaborate on wearables study

https://pharmaphorum.com/news/parexel-sanofi-wearables/

PAREXEL